Endogenous type I interferons as a defense against tumors.
about
Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancerInterferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancerNeutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor modelInterferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.Cytokine-induced tumor suppressors: a GRIM storyGRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.Differential activity of type I interferon subtypes for dendritic cell differentiationInhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding proteinThe role of type I interferons in intestinal infection, homeostasis, and inflammation.An IFN-γ-stimulated ATF6-C/EBP-β-signaling pathway critical for the expression of Death Associated Protein Kinase 1 and induction of autophagy.Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis.Impairment of IFN-alpha production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinomaCritical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1.A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.Novel delivery systems for interferons.Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cellsType I interferons in systemic autoimmunity.Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.Growing tumors induce a local STING dependent Type I IFN response in dendritic cells.GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.SUMOylation of p53 mediates interferon activitiesThe Protective Role of Type I Interferons in the Gastrointestinal Tract.Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine.A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas.Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype.
P2860
Q24202094-E551E277-181A-44D7-A30F-FA6AF674BEE2Q24203808-D9A76CBE-3DE9-40F9-AD7C-45FF4840971BQ24612339-4E3CC4D8-34A4-4BDE-AD88-EDFD7F2F31B1Q33920086-08AC4607-D9E1-4D9E-B952-1AF45CD506ECQ33967257-67D618D0-8FD8-4525-BAC5-536B91294153Q34077445-C8C7B066-C28D-4244-B071-4D9F7901F2E9Q34497752-E6923F13-8F65-4C39-B263-30B094C6A382Q34615006-4F35C458-411F-4210-8796-609CF25896D3Q35583231-C2322A6F-FE50-49A5-964A-B95ED9016678Q36001052-7447838B-FE32-40D8-9D7C-80DA7A5452E8Q36068837-01C928E1-B814-4A52-A654-F950E43E3DD6Q36382859-3D414B90-0010-4D78-9FF9-08E67E866A6DQ36497089-FC589DB6-593C-4FA9-83B5-1D19F7B28937Q36540282-5479431A-89ED-415A-A69A-39075AA3807EQ36544827-B2AE72F0-8CD1-43E2-99F2-F975CFB6EC66Q36685267-C422026A-5E32-4232-A23B-65F35EAB0AD5Q36937971-E69F1EDF-8F7B-4FAA-B199-35D902692370Q37620420-8C5290F4-8936-4556-840C-53D8A8B42387Q37713727-0A529F36-FC91-422F-8398-888418EF39D5Q38315801-11B31725-A1E9-498F-A5DF-48FFE64022D5Q38775242-5E3467E6-E72B-454E-9B76-38271EA067BDQ38962203-2AC536EF-5FB6-4692-BE44-2835B76639FFQ39106989-AE23BBF2-F872-4F09-BEF8-8698A5C78ED1Q39253724-96575B04-0FFA-4B01-92A4-34C884069866Q39399161-A43AF785-1ADC-4F8E-8191-0FBC95107D94Q40274291-3915DBBC-E8B4-4D37-9BA1-3952BF27DB73Q40639529-942A7F13-DA5F-426E-B9B5-D84F36A78040Q44370306-2E7D8B30-393F-4905-B767-BE3E97C07B8B
P2860
Endogenous type I interferons as a defense against tumors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Endogenous type I interferons as a defense against tumors.
@ast
Endogenous type I interferons as a defense against tumors.
@en
Endogenous type I interferons as a defense against tumors.
@nl
type
label
Endogenous type I interferons as a defense against tumors.
@ast
Endogenous type I interferons as a defense against tumors.
@en
Endogenous type I interferons as a defense against tumors.
@nl
prefLabel
Endogenous type I interferons as a defense against tumors.
@ast
Endogenous type I interferons as a defense against tumors.
@en
Endogenous type I interferons as a defense against tumors.
@nl
P1476
Endogenous type I interferons as a defense against tumors
@en
P2093
Ion Gresser
P304
P356
10.1016/S1359-6101(01)00035-1
P577
2002-04-01T00:00:00Z